Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Deangelo Ferguson

Plastic Surgery Detroit, MI Medical Doctor

NPI 1649702150 CMS profile 11316778

2799 W Grand Blvd, Detroit, MI 48202

Open in the dashboard

General payments

$9,905

62 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Deangelo Ferguson of Detroit, MI is reported in the CMS Open Payments database as having received $9,905 across 62 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $775 6
2024 General $3,421 19
2023 General $5,512 33
2022 General $197 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deangelo Ferguson
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Deangelo Ferguson were reported at $775. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Deangelo Ferguson Plastic Surgery median Middle half National median
2019 $0 $371 $122–$1,483 $163
2020 $0 $158 $52–$438 $114
2021 $0 $249 $87–$752 $132
2022 $197 $274 $102–$793 $149
2023 $5,512 $299 $113–$891 $160
2024 $3,421 $361 $124–$1,062 $164
2025 $775 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Smith+Nephew, Inc. $2,851 13 payments
  2. AbbVie, Inc. $2,734 10 payments
  3. Musculoskeletal Transplant Foundation Inc. $1,810 12 payments
  4. Integra LifeSciences Corporation $1,232 14 payments
  5. AxoGen $298 2 payments
  6. Kerecis Limited $153 1 payment
  7. Motiva USA, LLC $143 1 payment
  8. Avita Medical Americas, LLC $143 1 payment
  9. PolyNovo North America LLC $141 1 payment
  10. DePuy Synthes Sales Inc. $124 1 payment
  11. Other $276 6 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $5,412 10 payments
  2. Food and Beverage $4,493 52 payments
Products named General payments · program years 2022–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $5,304 18 payments
  2. Integra Extremity, Upper $2,621 8 payments
  3. REVOLVE $2,570 8 payments
  4. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $2,570 8 payments
  5. Ascension $2,210 8 payments
  6. FAST-FIX $2,087 7 payments
  7. NuGrip CMC Implant System $2,087 7 payments
  8. Ascension Silicone PIP $2,087 7 payments
  9. Integra Recon-Skin And Wound $1,117 13 payments
  10. Integra Recon-Skin And Wound $1,117 13 payments
  11. Other $6,134 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

62 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record